News Sentiment

NSPR sentiment intelligence

InspireMD Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.72 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+3.0% over one week, -1.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 3.0% Price confirming higher
Trend fit Trend inactive -1.4% over four weeks
Fair value -70.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 47
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 12
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 9
TradingView 6
TradingKey 6
GlobeNewswire 4
Motley Fool 3
Investing.com 2
StockStory 2

Event Lens

What the news is about

Classified themes
Earnings 26
Market update 26
Regulatory and legal 3
Analyst action 2
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
TradingView Direct company coverage

InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026

Raymond W. Cohen is resigning from his position as a Class III Director at InspireMD, effective July 1, 2026, due to personal considerations. He also served on the Audit Committee and Compensation Committee. The company's Nominating and Corporate Governance Committee will be resp

Tone
Negative 42/100
Event
Market update
Published
03 Jul 2026 07:29
Source
TradingView
Stock Titan Direct company coverage

Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026

InspireMD, Inc. reported that board member Raymond W. Cohen, a Class III director and member of the Audit and Compensation Committees, will resign effective July 1, 2026. His resignation is for personal considerations and is not due to any disagreement with the company. The Nomin

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Stock Titan
Moomoo Direct company coverage

Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4

Lake Street has reiterated its Buy rating on InspireMD (NSPR.US) but has adjusted its price target for the stock down to $4. This indicates a continued positive outlook on the company despite a revised valuation.

Tone
Neutral 50/100
Event
Analyst action
Published
30 Jun 2026 16:40
Source
Moomoo
www.marketscreener.com Direct company coverage

InspireMD, Inc.(NasdaqCM: NSPR) dropped from Russell 3000E Growth Benchmark

InspireMD, Inc. (NasdaqCM: NSPR) has been removed from the Russell 3000E Growth Benchmark. This news comes after several recent announcements from InspireMD regarding recalling actions on its CGuard Prime Carotid Stent System and enrolling the first patient in a new pivotal study

Tone
Negative 30/100
Event
Regulatory and legal
Published
29 Jun 2026 05:13
Source
www.marketscreener.com
TradingView Direct company coverage

NSPR Forecast — Price Target — Prediction for 2027

This article provides a stock forecast for InspireMD Inc. (NSPR) for 2027, including analyst price targets, historical performance data, and key financial metrics. It details the current stock price, volatility, market capitalization, and upcoming earnings report date, also highl

Tone
Neutral 50/100
Event
Analyst action
Published
28 Jun 2026 07:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of InspireMD Inc. – NASDAQ:NSPR

This article provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its price-to-book forward ratio. It appears to be an entry from a financial data platform, displaying market information, but the actual numerical value for the price-to-book forward r

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 17:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of InspireMD Inc. – NASDAQ:NSPR

This article provides the "Price to sales forward" value for InspireMD Inc. (NASDAQ: NSPR). The financial data is delivered by TradingView, sourcing information from ICE Data Services and FactSet Research Systems Inc.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 02:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of InspireMD Inc. – NASDAQ:NSPR

This article provides financial data for InspireMD Inc. (NASDAQ: NSPR), specifically focusing on its enterprise value to revenue forward. It appears to be a stub or a data point from a financial platform like TradingView, with no further analytical content but highlights the comp

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 01:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of InspireMD Inc. – NASDAQ:NSPR

This page from TradingView provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's financial overview within the health technology and medical specialties sector.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
TradingView
TradingKey Direct company coverage

InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of InspireMD Inc (NSPR), listing its major shareholders, their proportion of holdings, and recent changes in their positions. It also provides institutional shareholding data over several quarters, showing the number of institutions,

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 11:10
Source
TradingKey
TradingKey Direct company coverage

InspireMD Inc (NSPR) Institutional Confidence

InspireMD Inc (NSPR) has an institutional shareholding score of 3.00, placing it 132nd out of 203 in the Healthcare Equipment & Supplies industry. Institutional holdings represent 49.38% of shares outstanding, a 9.65% decrease quarter-over-quarter. James Simons is the largest ins

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 11:09
Source
TradingKey
TradingKey Direct company coverage

InspireMD Inc (NSPR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on InspireMD Inc (NSPR)'s dividend and stock split history. It notes that the company has not distributed dividends in the past five years and lists several 15-to-1 merger-type stock splits that occurred on April 15, 2021. The article also presents c

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 21:09
Source
TradingKey
TradingKey Direct company coverage

InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of InspireMD Inc (NSPR), detailing its current price momentum score of 5.92 and noting it trades between resistance at $0.96 and support at $0.58. It breaks down various technical indicators, with a majority signaling "Sell," and highlig

Tone
Negative 40/100
Event
Market update
Published
17 Jun 2026 11:09
Source
TradingKey
TradingKey Direct company coverage

InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis

InspireMD Inc's current financial score is 6.38, ranking 157 out of 203 in its industry, indicating robust financial status but low operating efficiency. The company reported a 122.24% year-over-year increase in quarterly revenue to $3.40M and a 22.60% increase in net profit. Key

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 11:09
Source
TradingKey
TradingKey Direct company coverage

InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates

InspireMD Inc (NSPR) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with forecasts ranging from $4.00 to $5.00, suggesting a significant upside. The market expects NSPR t

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 11:09
Source
TradingKey
Market source Direct company coverage

InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR

InspireMD announced positive 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm carotid stent implant used in TCAR procedures, meeting key safety and efficacy endpoints with a 100% acute device success rate and no adverse events. This data supports po

Tone
Positive 71/100
Event
Earnings
Published
16 Jun 2026 11:41
Source
Market source
Medical Buyer Direct company coverage

InspireMD announces inducement grants

InspireMD, Inc. has announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants, made outside of the company's 2021 Equity Incentive Plan under the 2024 Inducement Plan, are intended to

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 10:09
Source
Medical Buyer
The Manila Times Direct company coverage

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD, Inc. (Nasdaq: NSPR) announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants were made outside of the company's 2021 Equity Incentive Plan but under the 2024 Inducement Pl

Tone
Neutral 50/100
Event
Market update
Published
12 Jun 2026 20:09
Source
The Manila Times
Stock Titan Direct company coverage

Six new InspireMD employees receive 91,161-share stock grants

InspireMD (Nasdaq: NSPR) has announced inducement grants of 91,161 restricted shares to six new non-executive employees under its 2024 Inducement Plan. These equity awards, granted outside the 2021 Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4), will vest over three yea

Tone
Neutral 50/100
Event
Market update
Published
12 Jun 2026 20:09
Source
Stock Titan
MSN Direct company coverage

InspireMD, Inc. (NSPR) reports Q1 loss, tops revenue estimates

InspireMD, Inc. (NSPR) announced its first-quarter financial results, reporting a loss per share that was wider than analyst expectations but surpassing revenue estimates. The company posted a loss of 19 cents per share against an anticipated loss of 18 cents, while revenue reach

Tone
Neutral 50/100
Event
Earnings
Published
12 Jun 2026 00:39
Source
MSN
Stock Titan Direct company coverage

Stroke-prevention stent hits 100% success in 50 high-risk patients

InspireMD (NSPR) announced 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm stent used in TCAR procedures, showing 100% acute device success and no major adverse events in 50 high-risk patients. The company has a PMA supplement under FDA review with

Tone
Positive 73/100
Event
Earnings
Published
11 Jun 2026 12:39
Source
Stock Titan
Stock Titan Direct company coverage

InspireMD (NSPR) reports 100% device success in TCAR trial

InspireMD (NSPR) announced strong 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm implant used in TCAR procedures, showing 100% device success and no major adverse events in 50 patients. The company has a Premarket Approval supplement under FDA rev

Tone
Positive 75/100
Event
Earnings
Published
11 Jun 2026 11:39
Source
Stock Titan
GlobeNewswire Direct company coverage

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

InspireMD has announced the enrollment of the first patient in its CGUARDIANS III pivotal study, evaluating the SwitchGuard neuro protection system for use in TCAR procedures with the CGuard Prime 80 cm stent. This study aims to enhance patient safety and stroke prevention, build

Tone
Positive 72/100
Event
Market update
Published
09 Jun 2026 06:40
Source
GlobeNewswire
Finviz Direct company coverage

NSPR - InspireMD Inc Stock Price and Quote

This page provides a detailed overview of InspireMD Inc (NSPR) stock, including its current trading price, financial metrics, performance indicators, and recent news. It lists key financial data such as market cap, income, sales, and various ratios, alongside insider transaction

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 17:10
Source
Finviz
Stock Titan Direct company coverage

InspireMD (NSPR) holders OK 250M authorized shares, re-elect directors

InspireMD (NSPR) stockholders approved an amendment to increase the authorized number of common shares from 150 million to 250 million at their 2026 annual meeting. The stockholders also re-elected Marvin Slosman, Raymond Cohen, and Dan Dearen to the board of directors for three-

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 20:10
Source
Stock Titan